Form 8K Envista Holdings Corp For: 19 August By Investing.com
This article announces that Envista Holdings Corp filed a Form 8K on August 19. It is a brief report from Investing.com, providing basic information about the filing. The article provides no further details about the content of the Form 8K.
Envista Holdings appoints Paul Keel as board chair, announces executive awards
Envista Holdings has appointed Paul Keel, its President and CEO, as the new Chair of the Board, succeeding Scott Huennekens who will now serve as Lead Independent Director. Concurrently, the company announced significant compensation changes for Keel, including a substantial salary increase and a $10 million equity award, alongside a $1.5 million equity award for CFO Eric Hammes, reflecting strong financial performance with shares up 28% year-to-date. These executive appointments and awards follow impressive Q2 2026 financial results that exceeded Wall Street expectations.
Envista Holdings (NVST) CAO details options, RSUs and phantom shares in Form 3
Envista Holdings Corp.'s Chief Administrative Officer, Thomas Coree K., has filed a Form 3 detailing his initial beneficial ownership of the company's equity. This includes various employee stock options, restricted stock units (RSUs) with vesting schedules, and notional phantom shares linked to Envista stock through deferred contribution programs. The filing provides a breakdown of these holdings, their exercise prices, expiration dates, and vesting conditions, offering insight into Coree K.'s equity stake in NVST.
Zacks.com featured highlights include Envista, Sanmina, TAL Education and Avient
Zacks.com highlights four "PEG-Driven Value Stocks" for strong returns: Envista Corp. (NVST), Sanmina Corp. (SANM), TAL Education Group (TAL), and Avient Corp. (AVNT). The article explains the PEG ratio as a better indicator for value investing than P/E alone, helping investors identify stocks with potential for future earnings growth while avoiding "value traps." Each company is briefly described with its Zacks Rank, Value Score, and expected growth rate.
First Trust Advisors LP Has $1.39 Million Stock Holdings in Envista Holdings Corporation $NVST
First Trust Advisors LP significantly reduced its stake in Envista Holdings Corporation (NYSE:NVST) by 79.5% in the first quarter, now holding 54,922 shares valued at $1.39 million. Envista reported strong quarterly earnings, beating analyst estimates with an EPS of $0.41 and a 7.1% revenue increase, and provided optimistic fiscal 2026 EPS guidance. Despite this, analyst sentiment remains cautious, with a consensus "Hold" rating and an average price target of $29.31.
Analysts Conflicted on These Healthcare Names: Protagonist Therapeutics (PTGX), Qiagen (QGEN) and Envista Holdings (NVST)
Barclays analysts have offered varied ratings for several healthcare companies. Etzer Darout maintained a Buy rating for Protagonist Therapeutics (PTGX) with a $153.00 price target, while Luke Sergott gave Qiagen (QGEN) a Hold rating with a $38.00 target. Glen Santangelo maintained a Buy rating for Envista Holdings (NVST) with a $32.00 price target, noting a moderate buy consensus for the stock.
Dental company Envista reports 5% core sales growth in Q2
Envista Holdings Corporation (NYSE: NVST) reported strong second-quarter 2026 results, achieving 5.0% core sales growth and a 58% year-over-year increase in adjusted diluted EPS. The company raised its full-year 2026 guidance for core sales growth, adjusted EBITDA growth, and adjusted EPS, reflecting confidence in its continued performance. Envista also generated significant operating and free cash flow and repurchased shares during the quarter.
Earnings call transcript: Envista tops Q2 2026 estimates and raises outlook
Envista Holdings (NVST) exceeded Wall Street expectations for Q2 2026, reporting adjusted earnings of $0.41 per share on revenue of $730.5 million, surpassing analyst estimates. The company raised its full-year 2026 guidance, citing strong performance across its dental portfolio, increased margins, and robust free cash flow. Management highlighted new product innovation, market share gains, and productivity improvements as key drivers offsetting macroeconomic pressures and pricing changes in China.
NVST Q2 Deep Dive: Margin Expansion and Product Launches Amid China Market Shifts
Envista Holdings (NYSE:NVST) reported better-than-expected Q2 CY2026 results, with revenue up 7.1% year-on-year to $730.5 million and adjusted EPS beating estimates by 22.1%. The company's performance was driven by balanced growth across geographies, new product launches in endodontics and orthodontics, and margin expansion due to operational efficiencies. Envista is navigating China's volume-based procurement (VBP) reforms
Envista Holdings Corp 2026: Revenue $730.5M, EPS $0.33— 10-Q Summary
Envista Holdings Corp (NVST) reported strong results for the 2026 quarter, with revenue reaching $730.5M and diluted EPS of $0.33, indicating significant year-over-year growth. Net income more than doubled to $53.7M. The company experienced broad-based revenue growth, driven by volume and pricing increases, particularly in developed markets and within its Specialty and Equipment segments.
Envista Holdings Corp (NVST) (Q2 2026) Earnings Call Highlights: Strong Core Growth and Raised ...
Envista Holdings Corp (NVST) reported strong Q2 2026 results, with core sales up 5%, adjusted EBITDA increasing 28%, and adjusted EPS growing 58%. The company raised its full-year 2026 guidance due to broad-based growth across segments and geographies. However, anticipated headwinds include a Q4 slowdown due to fewer selling days, declines in the Brackets & Wires business, and significant price compression from China's Volume-Based Procurement initiatives.
Earnings call transcript: Envista tops Q2 2026 estimates and raises outlook
Envista Holdings reported strong Q2 2026 results, surpassing Wall Street expectations with adjusted EPS of $0.41 and revenue of $730.5 million. The company's stock rose significantly, driven by improved margins, higher cash flow, and a raised full-year outlook. Management attributed the success to broad-based strength across its dental portfolio, new product innovation, share gains, and productivity improvements, despite macro pressures and China pricing changes.
Envista Holdings (NYSE: NVST) doubles Q2 2026 profit on higher sales and cash flow
Envista Holdings (NYSE: NVST) reported a strong Q2 2026, doubling its net profit to $53.7 million compared to the previous year, driven by a 7.1% increase in sales to $730.5 million. The company's gross margin improved to 55.7% and operating margin to 11.0%, boosted by higher volumes, pricing strategies, and a $12.6 million tariff refund. For the first half of 2026, sales reached $1.44 billion, with net income exceeding $92.4 million, and the company generated $115.9 million in operating cash flow, which was used for acquisitions and share repurchases.
Envista Q2 2026 Earnings: Margin Expansion Supports Higher Guidance
Envista Holdings (NYSE: NVST) reported strong Q2 2026 earnings with revenue up 7.1% to $730.5 million and diluted EPS more than doubling. The company saw significant margin expansion across both GAAP and adjusted bases, driven by operational execution and a tariff refund, leading to an increase in full-year guidance for core sales growth, adjusted EBITDA growth, and adjusted diluted EPS. Despite the positive results, investors are advised to monitor risks such as execution against raised guidance, uneven segment growth, and full-year cash conversion.
Envista’s (NYSE:NVST) Q2 CY2026 Sales Beat Estimates
Envista Holdings (NYSE: NVST) reported strong Q2 CY2026 results, surpassing revenue and adjusted EPS expectations. The dental products company achieved 7.1% year-on-year sales growth and a non-GAAP profit significantly above analyst estimates, leading management to raise its full-year Adjusted EPS guidance. Despite a tepid long-term revenue growth, the recent performance shows improved efficiency and profitability.
Envista’s (NYSE:NVST) Q2 CY2026 Sales Beat Estimates
Envista Holdings (NYSE:NVST) reported strong Q2 CY2026 results, exceeding revenue and EPS expectations. The company's sales rose 7.1% year-on-year to $730.5 million, and non-GAAP profit was $0.41 per share, beating analyst estimates by 22.1%. Management also raised its full-year Adjusted EPS guidance, indicating a positive outlook.
Janus Henderson Group PLC Sells 53,900 Shares of Envista Holdings Corporation $NVST
Janus Henderson Group PLC reduced its stake in Envista Holdings Corporation (NYSE:NVST) by 11.3% in the first quarter, selling 53,900 shares, but still holds 421,915 shares valued at approximately $10.7 million. Envista recently saw a 2.1% increase in its stock price to $27.94, following a strong earnings report that surpassed analyst expectations with $0.36 EPS and $705.5 million in revenue. Despite mixed analyst views, the stock maintains a consensus "Hold" rating with an average target price of $28.62.
Envista earnings in focus: Can dental tech firm sustain momentum? By Investing.com
Envista Holdings Corp. is set to report its second-quarter results, with analysts expecting 34 cents per share on $716.6 million in revenue, reflecting year-over-year growth. Investors will be closely watching margin trajectory, segment performance, and competitive positioning, especially given the increased consolidation in the dental industry. The company had a strong first quarter, exceeding expectations, and the upcoming report will reveal if this momentum can be sustained amidst evolving market conditions.
Envista Holdings Corporation $NVST Shares Bought by Lazard Asset Management LLC
Lazard Asset Management LLC significantly increased its stake in Envista Holdings Corporation ($NVST) by 703.1% in the first quarter, acquiring an additional 69,099 shares, bringing its total holdings to 78,927 shares valued at $2.0 million. This comes as Envista exceeded quarterly earnings expectations, reporting $0.36 EPS against an estimated $0.31, with revenue up 14.4% year-over-year. Analyst sentiment for NVST is mixed but leans positive, with an average "Hold" rating and a price target of $28.62, while the company has provided a fiscal 2026 EPS guidance of $1.35 to $1.45.
Envista (NVST) To Report Earnings Tomorrow: Here Is What To Expect
Envista Holdings (NVST) is set to announce its earnings results, with analysts expecting a 5% year-on-year revenue growth. The company has a history of beating revenue expectations, and its stock price has remained unchanged in the last month, with an average analyst price target of $29.43. Peer performance in the healthcare equipment and supplies segment, like Align Technology and Baxter, offers some insight into potential outcomes.
Envista (NVST) To Report Earnings Tomorrow: Here Is What To Expect
Envista Holdings (NVST) is set to announce its earnings results this Wednesday. The market anticipates a 5% year-on-year revenue growth, a slowdown from the previous year's 7.7%. Analysts have largely maintained their estimates, and Envista has a strong track record of meeting Wall Street's revenue expectations.
Envista (NVST) To Report Earnings Tomorrow: Here Is What To Expect
Envista Holdings (NVST) is set to announce its earnings results this Wednesday. Analysts expect a 5% year-on-year revenue growth, a slowdown from the previous year's 7.7% increase. The company has a history of exceeding revenue estimates, and its stock price has remained stable recently, with analysts setting an average price target of $29.43.
Envista Holdings Corp expected to post earnings of 34 cents a share - Earnings Preview
Envista Holdings Corp is expected to report earnings of 34 cents per share. This information comes from a Refinitiv earnings preview. The full article can be accessed on TradingView, which aggregates news from various sources including Reuters.
Edgestream Partners L.P. Takes $2.62 Million Position in Envista Holdings Corporation $NVST
Edgestream Partners L.P. has acquired a new stake in Envista Holdings Corporation, purchasing 103,213 shares valued at approximately $2.62 million during the first quarter. Other institutional investors have also adjusted their holdings in Envista. The company recently reported strong quarterly earnings, beating estimates with $0.36 EPS and a 14.4% year-over-year revenue increase to $705.5 million, although analyst sentiment remains mixed with a consensus "Hold" rating.
Envista Holdings Number of Employees 2026 | Employee Count & Headcount Data
Envista Holdings Corp. (NVST) had approximately 12,067 employees worldwide as of March 2026, marking a 1.5% decline from 2023. Despite this reduction in headcount, the company is actively hiring, with 564 active job postings in 2026. The article provides detailed breakdowns of employee count by region, department, salary, and job opening trends, sourced from Revelio Labs workforce intelligence data.
Envista Holdings Corp (NVST) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of Envista Holdings Corp (NVST), highlighting its current valuation score of 7.77 within the Healthcare Equipment & Supplies industry. It details the company's P/E ratio, noting its position relative to recent highs and lows, and mentions that P/B, P/S, and P/CF data have not yet been disclosed. The data presented was last updated on 2026-07-30.
Envista (NVST) Stock Jumps 5.2%: Will It Continue to Soar?
Envista (NVST) stock surged 5.2% to $28.37, driven by investor optimism ahead of its Q2 2026 earnings release on August 5th. The company anticipates a 4.8% year-over-year revenue increase and a 26.9% increase in earnings per share to 33 cents. Despite the positive outlook, the Zacks Consensus EPS estimate for the quarter has remained unchanged, leading to a "Hold" rating from Zacks Investment Research.
Envista to Host Investor Day on September 17, 2026
Envista Holdings Corporation (NYSE: NVST) announced it will host an Investor Day on Thursday, September 17, 2026, from 9:00 a.m. to noon EDT. The event will feature a management presentation and a Q&A session, accessible via live webcast and replay on the company's investor relations website. In-person attendance requires advance registration.
Envista’s Sept. 17 Investor Day Will Stream Live With Q&A
Envista Holdings Corporation (NYSE: NVST) announced it will host an Investor Day on Thursday, September 17, 2026, from 9:00 a.m. to noon EDT. The event will feature a management presentation followed by a Q&A session and will be webcast live, with a replay available afterward. In-person attendance requires advance registration.
Envista Holdings Corp (NVST) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of Envista Holdings Corp (NVST)'s dividend and stock split history, noting that the company has distributed $0.00 in dividends over the past five years. It presents current stock performance data, including market capitalization and P/E ratio, and indicates that there is no dividend data available for the company.
Envista Holdings Corp (NVST) Institutional Confidence
Envista Holdings Corp (NVST) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. Institutional shareholding increased by 7.12% quarter-over-quarter to 125.03%. John Rogers is the largest institutional shareholder, holding 11.82 million shares.
NVST|Envista Holdings Corp|Price:26.330|Chg%:+0.140
Envista Holdings Corporation (NVST) is a global dental products company with over 30 dental brands, offering solutions for preventing, diagnosing, and treating dental conditions. The company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. Key executives and shareholder information are provided, detailing leadership and institutional holdings.
Envista Holdings Corp (NVST) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Envista Holdings Corp (NVST), detailing its current earnings forecast score, average price target, and analyst ratings. It highlights that the company has a strong buy trend based on 16 analysts, with an expected revenue of 716.45M for the next quarter and an anticipated EPS of USD 0.34. The article also includes a peer comparison in the Healthcare Equipment & Supplies industry.
Envista Holdings Corp (NVST) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a revenue breakdown for Envista Holdings Corp (NVST), detailing its regional revenue contributions. As of the specified update, the company has not yet disclosed relevant data for FY2025 by quarter or for business segment contributions. The current available data shows major revenue contributions from the United States, followed by "All Other" regions, and China.
Envista Holdings Corp (NVST) Cash Flow
This article presents the annual and quarterly cash flow statements for Envista Holdings Corp (NVST), covering operating, investing, and financing activities. It provides detailed financial figures and year-over-year changes for various cash flow components. Additionally, it includes a FAQ section defining key cash flow terms and presenting recent financial data for Envista Holdings.
NVST|Envista Holdings Corp|Price:26.330|Chg%:+0.140
Envista Holdings Corp (NVST) is a global dental products company with relatively healthy fundamentals and high growth potential. Its stock is currently considered fairly valued and analysts generally rate it as a "Buy" with a target price of $29.462. While the stock has traded sideways recently, it shows strong underlying company performance.
NVST|Envista Holdings Corp|Price:26.330|Chg%:+0.140
Envista Holdings Corp (NVST) shows strong fundamentals and high growth potential, despite trading sideways. The company is considered fairly valued within the Healthcare Equipment & Supplies industry and has high institutional ownership. Analysts have a positive outlook, with a 'Buy' rating and a target price suggesting a 12.58% upside.
Envista Holdings Corp (NVST) Financial Health: Profitability & Balance Sheet Analysis
Envista Holdings Corp (NVST) has a robust financial score of 8.14, ranking 40th in the Healthcare Equipment & Supplies industry. The company has shown strong financial performance with a 14.36% year-over-year revenue increase to $705.50 million and a significant 115.00% year-over-year net profit increase in its latest quarter. While its financial status is strong, its operating efficiency is noted as average.
NVST5876122 Bond Profile — Key Metrics
This article provides key metrics for the NVST5876122 bond, issued by Envista Holdings Corp. The bond has a 1.75% coupon rate and matures on August 15, 2028, with an outstanding amount of $500.25 million. Envista Holdings Corp. is detailed as a manufacturer and marketer of dental products, diagnostics, and treatment, operating through two main segments: Specialty Products and Technologies, and Equipment and Consumables.
Q1 Dental Equipment & Technology Earnings Review: First Prize Goes to Envista (NYSE:NVST)
Envista (NYSE:NVST) took the lead in the Q1 dental equipment & technology earnings season, reporting revenues of $705.5 million, a 14.4% year-on-year increase that exceeded analyst expectations by 4.5%. While Envista showed the fastest revenue growth, its stock saw a slight decline post-earnings, suggesting investor expectations were even higher. Other key players like Align Technology (NASDAQ:ALGN) and Dentsply Sirona (NASDAQ:XRAY) also beat revenue estimates, whereas Henry Schein (NASDAQ:HSIC) had the weakest performance against analyst estimates despite a subsequent stock increase.
Q1 Dental Equipment & Technology Earnings Review: First Prize Goes to Envista (NYSE:NVST)
Envista Holdings (NYSE:NVST) was highlighted as the top performer in the Q1 dental equipment & technology earnings season, reporting strong revenue growth that exceeded analyst expectations. The article reviews the performance of several key players in the dental equipment industry, noting market trends, challenges like economic uncertainty, and tailwinds such as advancements in digital dentistry. While Envista showed the fastest revenue growth, its stock saw a slight dip post-reporting, whereas Henry Schein experienced a significant surge despite being the "weakest Q1" against analyst estimates.
Q1 Dental Equipment & Technology Earnings Review: First Prize Goes to Envista (NYSE:NVST)
This article reviews the Q1 2026 earnings for four dental equipment and technology companies: Envista Holdings (NVST), Align Technology (ALGN), Henry Schein (HSIC), and Dentsply Sirona (XRAY). Envista is highlighted as the top performer with 14.4% year-on-year revenue growth, while Henry Schein had the weakest performance against analyst estimates. The sector as a whole showed strong Q1 results, with revenues beating estimates by 3%.
Envista Schedules Second Quarter 2026 Earnings Call
Envista Holdings Corporation (NYSE: NVST) announced it will report its second-quarter 2026 financial results on Wednesday, August 5, 2026. The company will host a conference call on the same day at 2:00 PM PT to discuss these results, which will also be webcast on its investor relations website. Envista is a global leader in the dental industry, known for its portfolio of technologies, consumables, and services.
Envista Schedules Second Quarter 2026 Earnings Call
Envista Holdings Corporation (NYSE: NVST) will report its second-quarter 2026 financial results on Wednesday, August 5, 2026. The company will host a conference call on the same day at 2:00 PM PT to discuss these results, with a live webcast available on its website. A replay of the webcast and related presentation materials will also be posted online.
Envista will discuss second-quarter 2026 results on Aug. 5
Envista Holdings Corporation (NYSE: NVST) is scheduled to report its second-quarter 2026 financial results on Wednesday, August 5, 2026. The company will also host an earnings conference call and webcast on the same day at 2:00 PM PT to discuss the results, which historically has led to neutral to negative market reactions. Investors can access the webcast and related materials via Envista's investor relations website, with a replay available for one year.
Envista Schedules Second Quarter 2026 Earnings Call
Envista Holdings Corporation (NYSE: NVST) has announced it will report its second quarter 2026 financial results on Wednesday, August 5, 2026. The company will host a conference call on the same day at 2:00 PM PT to discuss these results, which will also be webcast on its website. Envista, a global leader in the dental industry, will post its earnings press release and presentation materials on its "Investors" section prior to the call.
Envista Schedules Second Quarter 2026 Earnings Call
Envista Holdings Corporation (NYSE: NVST) has announced it will report its second-quarter 2026 financial results on Wednesday, August 5, 2026. The company will host a conference call and webcast on the same day at 2:00 PM PT to discuss these results. Interested parties can access the call via phone or through the "Investors" section of Envista's website.
Top 5 Stocks to Buy According to Ariel Investments
This article lists the top 5 stocks Ariel Investments is buying, highlighting Envista Holdings Corporation (NYSE:NVST) as one of them. Envista Holdings reported strong Q1 growth, with significant increases in core revenue, adjusted EBITDA, and EPS, and reiterated its positive full-year guidance. The company specializes in dental products and equipment and is a global medical technology firm spun off from Danaher Corporation.
Is Envista Holdings Corp (NVST) Overvalued After 3.1% Rally? GF
Envista Holdings Corp (NVST) saw its shares rally 3.1% to $27.17 on July 1, 2026, but GuruFocus' GF Value™ indicates the stock is currently overvalued by 13.8% at $23.87. Despite a strong GF Score™ of 80/100 suggesting solid fundamentals, its P/E ratio of 66.3x is significantly above its historical median, and a lack of insider transactions in the last three months raises concerns about insider confidence. Investors are advised to exercise caution due to the premium valuation.
Envista Holdings Corp. Financial Disclosures & Filings
This article provides a comprehensive list of Envista Holdings Corp.'s financial disclosures and regulatory filings, organized by year. It details earnings calls, annual general meetings, and conference presentations, offering insights into the company's performance, strategy, and investment decisions. Key highlights include financial growth figures, guidance updates, and strategic initiatives.
